Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Sensus Healthcare, Inc. (SRTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.69, marking a +1.3% move from the previous day.
Sensus Healthcare, Inc. (SRTS) Increases Despite Market Slip: Here's What You Need to Know
Sensus Healthcare, Inc. (SRTS) reachead $4.48 at the closing of the latest trading day, reflecting a +0.45% change compared to its last close.
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.69, moving +1.08% from the previous trading session.
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.78, moving +0.84% from the previous trading session.
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Sensus Healthcare: A Tough Q1 2025 Awaits Ahead
Q4 2024 showed a significant miss in profitability despite a 4% YoY sales growth; gross profit margin dropped due to a one-time discount for a new big client. The FDA initiatives are interesting, but they will bring a slowdown in sales as they are fully rolled out. Management has warned of a Q1 2025 with considerably lower sales due to the Fair Deal Agreements and seasonal factors.
Sensus Healthcare, Inc. (SRTS) Q4 2024 Earnings Call Transcript
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q4 2024 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, IR Joe Sardano - Chairman and CEO Michael Sardano - President & General Counsel Javier Rampolla - CFO Conference Call Participants Jeremy Pearlman - Maxim Group Arsalan Cameron - Roth Capital Partners Ben Haynor - Lake Street Capital Markets Operator Good day, and welcome to the Sensus Healthcare Fourth Quarter 2024 Financial Results Conference Call. [Operator Instructions].
Sensus Healthcare, Inc. (SRTS) Lags Q4 Earnings Estimates
Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.26 per share a year ago.
Sensus Healthcare (SRTS) Moves 19.9% Higher: Will This Strength Last?
Sensus Healthcare (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Sensus Healthcare, Inc. (SRTS) Exceeds Market Returns: Some Facts to Consider
Sensus Healthcare, Inc. (SRTS) closed at $6.92 in the latest trading session, marking a +1.91% move from the prior day.
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
Sensus Healthcare, Inc. (SRTS) reachead $6.77 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.
